A significant decrease was observed in the CCL24 level in the serum of RA patients (75.12 ± 69.59 ng/mL) as compared with HCs (125.3 ± 41.9 ng/mL) (p < 0.05) (Figure 2A). This evidence concerns the gene CCL24 and rheumatoid arthritis.